Roman DBDR Acquisition Corp. II Receives Nasdaq Delisting Notice for Listing Standard Violations
Roman DBDR Acquisition Corp. II received a Nasdaq delisting notice for failure to meet continued listing requirements, filing an 8-K under SEC Item 3.01 on August 24, 2026.
TLDR
- โRoman DBDR Acquisition Corp. II received Nasdaq delisting notice for listing standard violations, disclosed via 8-K filing
- โSPAC faces 45-day window to appeal or file compliance plan; redemption mechanics may be triggered by listing transfer
- โBusiness combination announcement is the only clear path to compliance โ monitor 8-K filings for Nasdaq appeal status
Editorial Self-Reviewยท70/100Review tier
- T1 SEC filing source โ authoritative and directly verifiable
- SPAC mechanics accurately explained
- Single source
Why this matters
Coverage sentiment: Bearish (0 bullish ยท 0 neutral ยท 1 bearish)
What to watch
- โข Roman DBDR 8-K filings: Nasdaq appeal filing within 45-day window โ confirms delisting fight vs acceptance
- โข Business combination announcement โ only clear path to listing standard compliance
Ripple effects
- โข SPAC sector: delisting notices signal continued post-2021 SPAC bubble unwinding across Nasdaq
AI-Synthesized news from multiple sources
This article was synthesized by AI from the source articles listed below, reviewed by a second-pass AI quality reviewer, and published by the market.news editorial system. How we do this ยท Editorial standards ยท Report an error
The Quick Take
- Roman DBDR Acquisition Corp. II (a SPAC) filed an 8-K on August 24, 2026, disclosing receipt of a Nasdaq delisting notice for failure to satisfy continued listing requirements.
- The notice triggers SEC Item 3.01 disclosure obligations, indicating the company has been formally warned that its listing is at risk of transfer or termination.
- SPAC investors face heightened uncertainty as the company must respond to Nasdaq or face a potential listing transfer that would reduce liquidity and institutional accessibility.
Roman DBDR Acquisition Corp. II, a special purpose acquisition company, filed an SEC 8-K disclosing that it received a notice from Nasdaq under Item 3.01 โ the SEC rule governing disclosure of delisting or failure to satisfy continued listing standards. The 252KB filing indicates the company has been formally notified that it no longer meets Nasdaq's continued listing requirements, triggering an appeals and compliance process. For SPAC investors, a Nasdaq delisting notice is a critical event because most SPACs are structured with redemption rights tied to continued exchange listing status, and a delisting could trigger early redemption mechanics.
The market implication for SPAC sector participants is notable. Roman DBDR Acquisition Corp. II joins a list of SPACs that have encountered delisting pressure as the post-2021 SPAC bubble continues to deflate. Nasdaq's listing requirements include minimum market value, bid price floors, and minimum shareholder equity thresholds โ all of which have become challenging for SPACs that failed to complete business combinations within the permitted timeframe. The broader SPAC market has seen significant redemption activity, leaving many vehicles with insufficient net asset value or shareholder count to meet minimum continued listing standards.
The forward signal to watch is whether Roman DBDR Acquisition Corp. II requests a Nasdaq appeal hearing within the standard 45-day window, which would grant a temporary reprieve while a compliance plan is reviewed. The macro variable is the overall SPAC deal pipeline โ a completed business combination transaction would provide a path to relisting compliance, while failure to close a deal within any extension period would likely accelerate the delisting. Investors should monitor the company's 8-K filings for updates on Nasdaq appeal status and any announced business combination target.
Synthesized from 1 source.
Market Intelligence Panel
Sentiment
BearishCoverage
livesource covering this story
Live Price
FOREXCOM:SPXUSD๐ Ripple Effects
- โธSPAC sector: delisting notices signal continued post-2021 SPAC bubble unwinding across Nasdaq
- โธSPAC redemption mechanics may be triggered if listing transfer removes exchange requirement compliance
- โธBroader SPAC de-SPAC pipeline pressure โ fewer target companies willing to merge with at-risk SPACs
๐ญ What to Watch Next
PRO- โธRoman DBDR 8-K filings: Nasdaq appeal filing within 45-day window โ confirms delisting fight vs acceptance
- โธBusiness combination announcement โ only clear path to listing standard compliance
- โธNasdaq SPAC delisting rate trend: systemic signal for 2021-vintage SPAC portfolio risk
Market news synthesis. Not financial advice. Sources cited above.
How the Story Spread
1 publisher covering this story
AI synthesis of every source listed below. Tier 1 = wire services (AP, Reuters via wire, Bloomberg, official central banks). Tier 2 = major financial publishers. Tier 3 = niche / specialist outlets. Click any card to read the original article.
โ Tier 1 โ Wire & primary sources
Get the Daily Briefing
Pre-market analysis every morning at 6am ET. Free.
Was this article useful?
Anonymous ยท helps us tune the editorial system
More ๐บ๐ธ United States Stories
PTC Therapeutics Acquisition Thesis: Sephience Growth and Gene Therapy FDA Approval Could Drive Upside
PTC Therapeutics acquisition thesis hinges on Sephience revenue growth and ST-920 FDA approval for Fabry disease
Aug 24, 2026
๐บ๐ธ United StatesSocial Security 2027 COLA Projected to Exceed 2026's 2.8% Raise but Medicare and Tax Headwinds May Offset Gains
Social Security's 2027 COLA is projected to exceed 2026's 2.8% raise based on CPI-W benchmarks, but Medicare premium increases and income tax thresholds may offset a significant portion of gross benefit gains for recipients.
Aug 24, 2026
๐บ๐ธ United StatesCardinal Health Medical Segment Head Sells $8.3M in Stock on August 18 as Executive Insider Sales Accelerate
Cardinal Health's medical segment head sold 35,000 shares for $8.3M on August 18, retaining $4.2M in direct holdings as part of the largest single-day multi-executive insider selling event at the company in recent history.
Aug 24, 2026